Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Trevi Therapeutics (TRVI)

Trevi Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRVI
DateTimeSourceHeadlineSymbolCompany
09/05/202412:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming ConferencesNASDAQ:TRVITrevi Therapeutics Inc
07/05/202421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRVITrevi Therapeutics Inc
07/05/202421:05PR Newswire (US)Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
01/05/202421:05PR Newswire (US)Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024NASDAQ:TRVITrevi Therapeutics Inc
23/04/202412:30Business WireFNB Harvest annonce les distributions d’avril 2024NASDAQ:TRVITrevi Therapeutics Inc
09/04/202412:30PR Newswire (US)Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International ConferenceNASDAQ:TRVITrevi Therapeutics Inc
04/04/202412:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming April EventsNASDAQ:TRVITrevi Therapeutics Inc
02/04/202412:30PR Newswire (US)Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership TeamNASDAQ:TRVITrevi Therapeutics Inc
21/03/202411:30Business WireFNB Harvest annonce les distributions de mars 2024NASDAQ:TRVITrevi Therapeutics Inc
20/03/202420:05PR Newswire (US)Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
13/03/202420:05PR Newswire (US)Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024NASDAQ:TRVITrevi Therapeutics Inc
28/02/202412:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming March EventsNASDAQ:TRVITrevi Therapeutics Inc
22/02/202412:30Business WireFNB Harvest annonce les distributions de février 2024NASDAQ:TRVITrevi Therapeutics Inc
16/02/202421:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRVITrevi Therapeutics Inc
16/02/202421:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRVITrevi Therapeutics Inc
16/02/202421:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRVITrevi Therapeutics Inc
15/02/202401:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRVITrevi Therapeutics Inc
14/02/202420:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRVITrevi Therapeutics Inc
06/02/202412:30PR Newswire (US)Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:TRVITrevi Therapeutics Inc
24/01/202412:30Business WireFNB Harvest annonce les distributions de janvier 2024NASDAQ:TRVITrevi Therapeutics Inc
04/01/202412:30PR Newswire (US)Trevi Therapeutics Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
29/12/202315:26Business WireFNB Harvest annonce les distributions annuelles finales réinvesties pour 2023NASDAQ:TRVITrevi Therapeutics Inc
21/12/202321:33Business WireFNB Harvest Distributions réinvesties annuelles estimatives révisées pour 2023NASDAQ:TRVITrevi Therapeutics Inc
18/12/202312:30Business WireFNB Harvest annonce les distributions de décembre 2023NASDAQ:TRVITrevi Therapeutics Inc
05/12/202312:30PR Newswire (US)Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:TRVITrevi Therapeutics Inc
30/11/202320:14Business WireFNB Harvest Distributions réinvesties annuelles estimées pour 2023NASDAQ:TRVITrevi Therapeutics Inc
17/11/202312:30Business WireFNB Harvest annonce les distributions de novembre 2023NASDAQ:TRVITrevi Therapeutics Inc
09/11/202321:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRVITrevi Therapeutics Inc
09/11/202321:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRVITrevi Therapeutics Inc
09/11/202321:05PR Newswire (US)Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TRVITrevi Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TRVI

Your Recent History

Delayed Upgrade Clock